石大勝華(603026.SH):子公司擬投建2萬噸/年正極補鋰劑項目
格隆匯2月14日丨石大勝華(603026.SH)公佈,公司全資子公司勝華新能源科技(東營)有限公司擬投資建設2萬噸/年正極補鋰劑項目。項目預計總投資9.35億元,其中建設投資為6.47億元,流動資金為2.88億元。該項目投資資金全部為自籌資金。
項目建設地為山東省東營市墾利區同興路198號,佔地面積為30,015㎡,該項目分兩期建設:其中一期建設內容為5,000噸/年正極補鋰劑裝置及配套設施,計劃2024年2月建成,投資額為2.35億元;二期建設內容為15,000噸/年正極補鋰劑裝置及配套設施,投資額為7億元,根據市場情況擇機建設,建設期12個月。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.